You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Buy Disclosure
Sukhtian Ghiath M. · SEC Form 4 · Filed Jun 1, 2026
Buy
Reported value range
Not reported
Sukhtian Ghiath M. Director / Ten Percent Owner
OTLK
Outlook Therapeutics
OTLK
Transaction date
May 28, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 4 days later
OTLK daily price context
Close on/before transaction
$0.74
May 28, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Warrants (right to buy) on Common Stock
- Quantity / price
- 3,458,571 shares
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0000899140-26-000620
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$5M
Buys / sales
4 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK | Expiration | May 28, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK | Buy | May 28, 2026 | $5M |
| Outlook Therapeutics, Inc. OTLK | Expiration | May 28, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK | Buy | May 28, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK Current | Buy | May 28, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK | Expiration | May 28, 2026 | Not reported |
| Outlook Therapeutics, Inc. OTLK | Buy | May 28, 2026 | Not reported |